Evidence Generation Strategic Partnership for Heart Failure Studies

UBC was selected by a major pharmaceutical company to manage a portfolio of 5 studies of patients with heart failure to generate evidence in support of a new product launch.

The portfolio of studies was designed to provide insights into disease progression and treatment patterns in a real word setting as well as to assess potential novel efficacy domains that warranted deeper investigation following the pivotal studies supporting product approval.  The evidence generated was important to support publications and potential changes to treatment guidelines and label information.

Explore UBC’s expertise in real world evidence and clinical development.